Published in Int Urol Nephrol on March 10, 2011
Are acquired cystic kidney disease and autosomal dominant polycystic kidney disease risk factors for renal cell carcinoma in kidney transplant patients? J Nephropathol (2012) 0.81
Malignancies in a renal transplant population: The St. Michael's Hospital experience. Urol Ann (2016) 0.75
De novo malignancy in organ transplant recipients in Taiwan: a nationwide cohort population study. Oncotarget (2016) 0.75
Acquired cystic kidney disease: an under-recognized condition in children with end-stage renal disease. Pediatr Nephrol (2017) 0.75
Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma. N Engl J Med (2007) 24.19
Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol (1982) 8.47
Guideline for management of the clinical T1 renal mass. J Urol (2009) 8.26
Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor. Nat Med (2002) 7.06
The Heidelberg classification of renal cell tumours. J Pathol (1997) 5.36
Cancer after kidney transplantation in the United States. Am J Transplant (2004) 5.08
Incidental renal cell carcinoma-age and stage characterization and clinical implications: study of 1092 patients (1982-1997). Urology (2000) 2.92
Renal cell carcinoma in transplant recipients with acquired cystic kidney disease. Clin J Am Soc Nephrol (2007) 1.95
Recommendations for the outpatient surveillance of renal transplant recipients. American Society of Transplantation. J Am Soc Nephrol (2000) 1.90
Native renal cysts and dialysis duration are risk factors for renal cell carcinoma in renal transplant recipients. Am J Transplant (2010) 1.65
Sirolimus in metatastic renal cell carcinoma. J Clin Oncol (2008) 1.47
Ultrasonic diagnosis of renal cell carcinoma in hemodialysis patients. J Urol (1994) 1.43
Prevalence of acquired cystic kidney disease and tumors in native kidneys of renal transplant recipients: a prospective US study. Radiology (1995) 1.41
Primary kidney tumors before and after renal transplantation. Transplantation (1995) 1.38
Posttransplant malignancies. Transplant Proc (1999) 1.27
Renal cell carcinoma of native kidney in renal transplant recipients. BJU Int (2006) 1.26
Cancer development in patients progressing to dialysis and renal transplantation. Transplant Proc (1985) 1.14
Cancer risk after renal transplantation in Japan. Int J Cancer (1997) 1.13
Renal neoplasia and acquired cystic kidney disease in patients receiving long-term dialysis. Arch Pathol Lab Med (1986) 1.02
Minimizing the risk of posttransplant malignancy. Transplantation (2009) 0.97
De novo renal cell carcinoma of native kidney in renal transplant recipients. Cancer (2005) 0.92
Improvement in survival of patients with renal cell carcinoma--the role of the serendipitously detected tumor. J Urol (1988) 0.92
Renal cell carcinoma of end-stage renal disease: an analysis of chromosome 3, 7, and 17 abnormalities by microsatellite amplification. Mod Pathol (1999) 0.86
Renal cell carcinoma detected by screening shows better patient survival than that detected following symptoms in dialysis patients. Ther Apher Dial (2004) 0.85
Renal neoplasias in patients receiving dialysis and renal transplantation: clinico-pathological features and p53 gene mutations. Transplantation (1999) 0.83
Renal cell carcinoma of native kidneys: prospective study of 129 renal transplant patients. J Urol (1997) 0.82
Renal cell carcinoma of native kidney after renal transplantation: clinical relevance of early detection. Transplant Proc (2009) 0.82
Renal cell carcinoma of native kidneys in renal transplant recipients. Transplant Proc (1998) 0.81
Malignancies of the genito-urinary system following renal transplantation. Br J Urol (1995) 0.80
[The clinical significance of renal cell carcinoma in dialysis dependent patients in comparison with kidney transplant recipients]. Urologe A (1997) 0.80
Comparison of ultrasonography, computerized tomography and angiography in dialysis patients with renal cell carcinoma. Urol Int (1992) 0.78
Lamivudine in hepatitis B-associated membranous nephropathy. Kidney Int (2005) 3.03
miR-130b Promotes CD133(+) liver tumor-initiating cell growth and self-renewal via tumor protein 53-induced nuclear protein 1. Cell Stem Cell (2010) 2.87
Aldehyde dehydrogenase discriminates the CD133 liver cancer stem cell populations. Mol Cancer Res (2008) 2.82
Genome-wide association study in Asian populations identifies variants in ETS1 and WDFY4 associated with systemic lupus erythematosus. PLoS Genet (2010) 2.74
Video-assisted thoracoscopic talc pleurodesis is effective for maintenance of peritoneal dialysis in acute hydrothorax complicating peritoneal dialysis. Nephrol Dial Transplant (2003) 2.39
Preemptive lamivudine therapy based on HBV DNA level in HBsAg-positive kidney allograft recipients. Hepatology (2002) 1.84
Toll-like receptor 4 promotes tubular inflammation in diabetic nephropathy. J Am Soc Nephrol (2011) 1.72
Alleviation of sleep apnea in patients with chronic renal failure by nocturnal cycler-assisted peritoneal dialysis compared with conventional continuous ambulatory peritoneal dialysis. J Am Soc Nephrol (2006) 1.61
Disruption of the Smad7 gene promotes renal fibrosis and inflammation in unilateral ureteral obstruction (UUO) in mice. Nephrol Dial Transplant (2008) 1.56
Pilot study of pegylated interferon-alpha 2a in dialysis patients with chronic hepatitis C virus infection. Nephrology (Carlton) (2007) 1.55
Expression of frizzled-related protein and Wnt-signalling molecules in invasive human breast tumours. J Pathol (2002) 1.53
Albumin stimulates interleukin-8 expression in proximal tubular epithelial cells in vitro and in vivo. J Clin Invest (2003) 1.51
Treatment of refractory pseudomonas aeruginosa exit-site infection by simultaneous removal and reinsertion of peritoneal dialysis catheter. Perit Dial Int (2006) 1.51
Meta-analysis followed by replication identifies loci in or near CDKN1B, TET3, CD80, DRAM1, and ARID5B as associated with systemic lupus erythematosus in Asians. Am J Hum Genet (2012) 1.49
CD133(+) liver tumor-initiating cells promote tumor angiogenesis, growth, and self-renewal through neurotensin/interleukin-8/CXCL1 signaling. Hepatology (2012) 1.48
Mannose binding lectin level and polymorphism in patients on long-term peritoneal dialysis. Nephrol Dial Transplant (2005) 1.40
Kidney injury molecule-1: more than just an injury marker of tubular epithelial cells? J Cell Physiol (2013) 1.40
Prognostic and diagnostic significance of beta-catenin nuclear immunostaining in colorectal cancer. Clin Cancer Res (2004) 1.34
Anti-DNA antibodies in the pathogenesis of lupus nephritis--the emerging mechanisms. Autoimmun Rev (2007) 1.27
Lupus nephritis: induction therapy in severe lupus nephritis--should MMF be considered the drug of choice? Clin J Am Soc Nephrol (2012) 1.25
Mechanism of chronic aristolochic acid nephropathy: role of Smad3. Am J Physiol Renal Physiol (2010) 1.24
ITGAM is associated with disease susceptibility and renal nephritis of systemic lupus erythematosus in Hong Kong Chinese and Thai. Hum Mol Genet (2009) 1.24
Activation of p53 promotes renal injury in acute aristolochic acid nephropathy. J Am Soc Nephrol (2009) 1.24
Essential role for Smad3 in angiotensin II-induced tubular epithelial-mesenchymal transition. J Pathol (2010) 1.20
Intrinsic cells: mesothelial cells -- central players in regulating inflammation and resolution. Perit Dial Int (2009) 1.19
Peritoneal mesothelial cell culture and biology. Perit Dial Int (2006) 1.17
Identification of PTK6, via RNA sequencing analysis, as a suppressor of esophageal squamous cell carcinoma. Gastroenterology (2012) 1.16
Outcome and prognostic indicators of diffuse proliferative lupus glomerulonephritis treated with sequential oral cyclophosphamide and azathioprine. Arthritis Rheum (2002) 1.16
Sonographic features of ileal duplication cyst at 12 weeks. Prenat Diagn (2002) 1.16
Fibrolamellar hepatocellular carcinoma. Am J Gastroenterol (2009) 1.14
The pathogenic role of the renal proximal tubular cell in diabetic nephropathy. Nephrol Dial Transplant (2012) 1.13
Prevalence of chronic kidney disease in Chinese HIV-infected patients. Nephrol Dial Transplant (2007) 1.12
A CD90(+) tumor-initiating cell population with an aggressive signature and metastatic capacity in esophageal cancer. Cancer Res (2013) 1.12
Peroxisome proliferator-activated receptor-gamma contributes to the inhibitory effects of Embelin on colon carcinogenesis. Cancer Res (2009) 1.11
Long-term study of mycophenolate mofetil treatment in IgA nephropathy. Kidney Int (2009) 1.11
Clinicopathological significance of missing in metastasis B expression in hepatocellular carcinoma. Hum Pathol (2007) 1.11
Quantification of plasma beta-catenin mRNA in colorectal cancer and adenoma patients. Clin Cancer Res (2004) 1.10
Cytokines and their roles in the pathogenesis of systemic lupus erythematosus: from basics to recent advances. J Biomed Biotechnol (2010) 1.10
Rab25 is a tumor suppressor gene with antiangiogenic and anti-invasive activities in esophageal squamous cell carcinoma. Cancer Res (2012) 1.09
Mice overexpressing latent TGF-beta1 are protected against renal fibrosis in obstructive kidney disease. Am J Physiol Renal Physiol (2008) 1.09
Anti-dsDNA antibodies bind to mesangial annexin II in lupus nephritis. J Am Soc Nephrol (2010) 1.09
Risks and outcomes of peritonitis after flexible colonoscopy in CAPD patients. Perit Dial Int (2007) 1.08
Diabetic tubulopathy: an emerging entity. Contrib Nephrol (2011) 1.08
Activation of tubular epithelial cells by mesangial-derived TNF-alpha: glomerulotubular communication in IgA nephropathy. Kidney Int (2005) 1.07
Incidence and outcome of antiglomerular basement membrane disease in Chinese. Nephrology (Carlton) (2004) 1.06
Autoantibodies and resident renal cells in the pathogenesis of lupus nephritis: getting to know the unknown. Clin Dev Immunol (2012) 1.05
Tuberculosis in systemic lupus erythematosus in an endemic area and the role of isoniazid prophylaxis during corticosteroid therapy. J Rheumatol (2005) 1.05
The TLR4 antagonist CRX-526 protects against advanced diabetic nephropathy. Kidney Int (2013) 1.04
Histological regression of squamous esophageal carcinoma assessed by percentage of residual viable cells after neoadjuvant chemoradiation is an important prognostic factor. Ann Surg Oncol (2010) 1.03
Mycophenolate mofetil alleviates persistent proteinuria in IgA nephropathy. Kidney Int (2005) 1.03
A veno-caliceal fistula related to ureteric stricture in a kidney allograft masquerading as renal failure. Am J Kidney Dis (2007) 1.03
MicroRNA-616 induces androgen-independent growth of prostate cancer cells by suppressing expression of tissue factor pathway inhibitor TFPI-2. Cancer Res (2011) 1.03
Effect of human anti-DNA antibodies on proximal renal tubular epithelial cell cytokine expression: implications on tubulointerstitial inflammation in lupus nephritis. J Am Soc Nephrol (2005) 1.02
Smad7 transgene attenuates peritoneal fibrosis in uremic rats treated with peritoneal dialysis. J Am Soc Nephrol (2007) 1.00
Delaying initiation of dialysis till symptomatic uraemia--is it too late? Nephrol Dial Transplant (2007) 1.00
Pathophysiological changes to the peritoneal membrane during PD-related peritonitis: the role of mesothelial cells. Mediators Inflamm (2012) 1.00
Growth hormone treatment during hemodialysis in a randomized trial improves nutrition, quality of life, and cardiovascular risk. J Am Soc Nephrol (2007) 1.00
Tubular expression of angiotensin II receptors and their regulation in IgA nephropathy. J Am Soc Nephrol (2005) 1.00
Cysteine-rich intestinal protein 2 (CRIP2) acts as a repressor of NF-kappaB-mediated proangiogenic cytokine transcription to suppress tumorigenesis and angiogenesis. Proc Natl Acad Sci U S A (2011) 0.99
ELF1 is associated with systemic lupus erythematosus in Asian populations. Hum Mol Genet (2010) 0.99
Clinicopathologic analysis of renal biopsies after haematopoietic stem cell transplantation. Nephrology (Carlton) (2008) 0.98
Rapamycin attenuates the severity of established nephritis in lupus-prone NZB/W F1 mice. Nephrol Dial Transplant (2008) 0.98
Improvement in sleep apnea during nocturnal peritoneal dialysis is associated with reduced airway congestion and better uremic clearance. Clin J Am Soc Nephrol (2008) 0.98
Viral nephropathy. Nat Clin Pract Nephrol (2006) 0.98
Roles of neutrophil gelatinase-associated lipocalin in continuous ambulatory peritoneal dialysis-related peritonitis. J Clin Immunol (2009) 0.97
Tumor suppressor dual-specificity phosphatase 6 (DUSP6) impairs cell invasion and epithelial-mesenchymal transition (EMT)-associated phenotype. Int J Cancer (2011) 0.97
A combination of biocompatible peritoneal dialysis solutions and residual renal function, peritoneal transport, and inflammation markers: a randomized clinical trial. Am J Kidney Dis (2012) 0.97
Streptococcus gordonii peritonitis in a patient on CAPD. Ren Fail (2011) 0.97
Macromolecular IgA1 taken from patients with familial IgA nephropathy or their asymptomatic relatives have higher reactivity to mesangial cells in vitro. Kidney Int (2009) 0.96
Influence of different allelic variants of the CYP3A and ABCB1 genes on the tacrolimus pharmacokinetic profile of Chinese renal transplant recipients. Pharmacogenomics (2006) 0.95
Elevated glucose induction of thrombospondin-1 up-regulates fibronectin synthesis in proximal renal tubular epithelial cells through TGF-beta1 dependent and TGF-beta1 independent pathways. Nephrol Dial Transplant (2006) 0.95
Catalytic activity of Matrix metalloproteinase-19 is essential for tumor suppressor and anti-angiogenic activities in nasopharyngeal carcinoma. Int J Cancer (2011) 0.95
Mediators of inflammation and their effect on resident renal cells: implications in lupus nephritis. Clin Dev Immunol (2013) 0.95
Extracellular protease ADAMTS9 suppresses esophageal and nasopharyngeal carcinoma tumor formation by inhibiting angiogenesis. Cancer Res (2010) 0.95
Cytoplasmic Forkhead box M1 (FoxM1) in esophageal squamous cell carcinoma significantly correlates with pathological disease stage. World J Surg (2012) 0.94